John Erikson, M.D., Ph.D., a cardiologist specializing in
cardiovascular imaging, is Professor of Medicine in the Cardiology Division at
The University of Texas Health Science Center in San Antonio, Texas and Program
Director of the Cardiovascular Disease Fellowship. He is a staff physician at the University
Health System’s University Hospital, Audie L. Murphy Memorial Veterans
Administration Hospital, UT Medicine, and CHRISTUS Santa Rosa Medical Center, Medical
Director of the University Hospital Non-Invasive Laboratories, and Medical Director of the Bartter Research
Unit at the Audie L. Murphy Memorial Veteran’s Hospital.
After completing undergraduate
study in biochemistry at North
University, Dr. Erikson
attended medical and graduate school at Southwestern Medical
Center in Dallas, Texas
where he received his M.D. and Ph.D. degrees, and completed his residency training
at Parkland Memorial Hospital. He received his cardiology training at Southwestern
Medical Center and received advanced echocardiography training at Washington
University School of Medicine and Barnes Hospital before joining the faculty in
San Antonio, where he participates in patient care, teaching, and clinical
research. He has been elected to
Fellowship in the, American College of Cardiology, American Society of
Echocardiography, and American Heart Association.
Dr. Erikson has received grant
support from the Texas Affiliate of the American Heart Association to study
proinflammatory cytokines in acute ischemia/reperfusion and investigating novel
delivery techniques for gene therapy in the acute setting. His current research and clinical interests
are related to non-invasive imaging, valvular heart disease, and percutaneous
Del Rincn I, Polak JF, Leary DH, Battafarano DF, Erikson JM, Restrepo JF, Molina E, Escalante A. Systemic inflammation and cardiovascular risk factors predict rapid progression of atherosclerosis in rheumatoid arthritis. Annals Rheum Dis 2014 May;.
Del Rincn I, Battafarano DF, Restrepo JF, Erikson JM, Escalante A. Glucocorticoid dose thresholds associated with all-cause and cardiovascular mortality in rheumatoid arthritis. Arthritis Rheum 2014 Jan;66(2):264-272.
Xu X, Zhao W, Wan W, Ji LL, Powers AS, Erikson JM, Zhang JQ. Exercise training combined with angiotensin II receptor blockade reduces oxidative stress after myocardial infarction in rats. Exp Physiol 2010 Jul;95(10):1008-1015.
Xu X, Zhao W, Lao S, Wilson BS, Erikson JM, Zhang JQ. Effects of exercise and L-arginine on ventricular remodeling and oxidative stress. Med Sci Sports Exerc 2010 Jan;42(2):346-354.
Ladenson PW, McCarren M, Morkin E, Edson RG, Shih MC, Warren SR, Barnhill JG, Churby L, Thai H, OBrien T, Anand I, Warner A, Hattler B, Dunlap M, Erikson J, Goldman S. Effects of the thyromimetic agent diiodothyropropionic acid on body weight, body mass index, and serum lipoproteins: a pilot prospective, randomized, controlled study. J Clin Endocrinol Metab 2010 Jan;95:1349-1354.